Clinical trialNCT00410826CompletedPhase 2Interventional

Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer

SponsorUniversity of WashingtonEnrollment204Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the NasopharynxStage III Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the Hypopharynx+4 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Renato Martins
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
University of New Mexico Health Science Ccop
Albuquerque, New Mexico, United States
University of North Carolina
Chapel Hill, North Carolina, United States
New Hanover Radiation Oncology Center
Wilmington, North Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
University of Tennessee Cancer Institute-Boston Cancer Group Plc
Memphis, Tennessee, United States
Fred Hutchinson Cancer Research Center/university of Washington Cancer Consortium
Seattle, Washington, United States
Multicare Health System
Tacoma, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2006
Primary completion: 31 May 2012
Completion: —
Last update posted: 10 May 2013
Registered enrollment: 204
Registry id: NCT00410826

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.